Vlajinac Š, H, Marinković J I. Umiranje od raka želuca u beogradskoj populaciji u periodu od 1999. 2002;(9):655–60.
2.
Hauser M, Kirk R, Martinez J, Finn N, K. Navigation end Paliative Care. Cancer. 2011;3585–91.
3.
João V, Fonseca. Nursing care needs of the caregiver of persons under palliative care, rev Bras Enferm. Brasília. 2011;(1):180–4.
4.
Jovanović L. Zbornik radova Novi sad. 2007;21–4.
5.
Shoemaker L, Estfan B, Induru R W. symptom management: an important part of cancer care. 2011;(1):25–34.
6.
Chang, Lorenz K, K, Bui B, T. Pain end palliative medicine. journal of rehabilitation research end development. 2007;(2):279–94.
7.
Beleslin. Kancerski bol i sinonimi zavisnosti: zablude i izazovi. Monografije naučnih skupova aMN sLd, serija B. 2007;(1):1–24.
8.
Lindqvist O, Lundquist G, Bükki, Lunder U, Hagelin C. Four Essential drugs Needed for Quality Care of the dying: a delphi-study Based International Expert Consensus Opinion. j Palliat Med. 2013;(1):38–43.
9.
O Regan D. Filshe j acupuncture end Cancer autonomic Neuroscience: Basic and Clinical. 2010;96–100.
10.
Hauser R, Sileo M, Kirk R, Martinez J, Finn N, K. Navigation end Paliative Care Cancer. 2011;3585–91.
11.
Morassutti I. Nutritional intervention for improving treatment tolerance in cancer patients. Current Opinion in Oncology. 2011;322–30.
12.
Mastoraki, Lefantzis N, G. Controversies and challenging therapeutic modalities in gastric cancer. Indian j surg. 2011;(4):251–5.
13.
Tokunaga M, Terashima M, Tanizawa Y, Bando E, Kawamura T, Yasui H, et al. survival benefit of palliative gastrectomy in gastric cancer patients with peritoneal metastasis. World j surg. 2012;(11):2637–43.
14.
Cheng H, Cs L, Lin C, Cheng C, Tang Jh, Tsou Y. Treatment of malignant gastric outlet obstruction with metallic stents: assessment of whether gastrointestinal position alters efficacy. j Investig Med. 2012;(7):1027–32.
15.
Bosaeus I. Nutritional support in multimodal therapy for cancer cachexia. support Care Cancer. 2008;447–51.
16.
Harris D . Nausea and vomiting in advanced cancer. British Medical Bulletin. 2010;175–85.
17.
Gupta M, Davis M, Legrand, Walsh. Lagman r. Nausea and Vomiting in advanced Cancer. The Cleveland Clinic Protocol" j support Oncol. 2012;
18.
Schwartzberg L. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives. j support Oncol. 2007;(2):5–12.
19.
Mackay S. Management of gastric cancer. reprinted from australian. Family Physician. 2006;(4):208–11.
20.
Hazin, Tamimi T. Zein NN. recognizing and treating cutaneous signs of liver disease. Cleve Clin j Med. 2009;(10):599–606.
21.
De Bellis M, Palaia, Di Girolamo C, Cascella E, Fiore M, F. Is preoperative endoscopic biliary drainage indicated for jaundiced patients with resectable pancreatic cancer? Curr drug Targets. 2012;(6):753–63.
22.
Sorensen H, Mellemkjar L. Long-term surrvival and cause specific mortality in patienants with cirrhosis of the liver; a nationwide cohort study in denmark. Clin Epidemiol. 2003;(19):88–93.
23.
Cardenas, Gines P. Management of complications of cirrhosis in patientsawaiting liver transplantation. journal of Hepatol. 2005;(42):124–33.
24.
Sargent S. Management of patients with advanced liver cirrhosis. Nursing standard. 2006;(11):48–56.
25.
Runyon Ba. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;(6):2087–107.
26.
Marrero J F, Martinez R, Hyzy. Critical Care Hepatology amercan journal respiratory Critical Care Medicine. 2003;1421–6.
27.
Heidelbaugh J.J. Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment american Family Physician. 2006;(5).
28.
Ferenci P. Hepatic encephalopathy. 2003;
29.
James Y, Findlay F, Paugam-Burtz C, Liu L, Stephen. Liver Transplantation. 2011;496–510.
30.
Chadalavada, Biyyani R.S M, Mullen K. Nutrition in Hepatic Encephalopathy. Nutrition in Clinical Practice. 2010;3.
31.
Prakash R, Mullen K. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat rev Gastroenterol Hepatol. 2010;515–25.
32.
Perumalswami P, Td. The Management of Hospitalized Patients with Cirrhosis: The Mount sinai Experience and a Guide for Hospitalists. dig dis sci. 2011;(5):1266–81.
33.
Mccormick Pa O, Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut. 2001;682–5.
34.
Vračarević V, Handnadjev Lj, Petrović Z, Damjanov. Experience in the treatment of some complications of portal hypertension inalcoholic liver cirrhosis. Vojnosanit Pregld. 2011;(11):917–22.
35.
Mancinella A, Mancinella M, Marigliano B, Marigliano V. Cirrhotic spontaneous bacterial peritonitis in the elderly. recenti Prog Med. 2011;(1):28–32.
36.
Nendaz M, Morard I. antibiotic prophylaxis in liver cirrhosis. rev Med suisse. 2012;(326):278–81.
37.
Boyd K, Kimbell B, Murray, Iredale. Living and dying well with end-stage liver disease: time for palliative care? Hepatology. 2012;(6):1650–1.
38.
Milićević N, Kovčin V, Babić M. Palijativno zbrinjavanje obolelih od maignih bolesti. srpski arhiv za celokupno lekarstvo. 2001;1–2.
39.
Morrison S M, Care. The New England journal of Medicine. 2004;2582–90.
40.
Wills LST, Palmer R, Ugboma D, Addington -Hall J H, Coombs M. Negotiated dying: a grounded theory of how nurses shape withdrawal of treatment in hospital critical care units. International journal of Nursing studies. (12):1466–74.
41.
Chodinov M. dying, dignity, and new horizons in palliative end-of-life care. Ca: a Cancer journal for. Clinicians. 2006;(2):84–103.
42.
Cheng SY, Dy S, Fang PH, Chen CY, Chiu TY. Evaluation of Inpatient Multidisciplinary Palliative Care Unit on Terminally Ill Cancer Patients from Providers’ Perspectives: A Propensity Score Analysis. Japanese Journal of Clinical Oncology. 2012;43(2):161–9.
43.
Carl Johan F. Perspectives on palliative care: sweden. support Care Cancer. 2000;441–3.
44.
Ns K, Ca L, Ka P, Cortez T, Livote E, Penrod. autor za korespondenciju: željko Vlaisavljević Clinical center of serbia-Clinic for Gastroenterology dr Koste Todorovica st. journal of Palliative Medicine. 2011;(12):1325–32.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.